Find a Clinical Trial

Filter By:

Title	Investigator
2-[¹⁸F]-Deoxy-D-Glucose (FDG) and [¹⁸F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer [Protocol 00-095]	Morris, Michael, MD
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer [Protocol 09-054]	Dalbagni, Guido, MD
A Feasibility Study of the Effects of a Directed Exercise Program for Breast Cancer Patients Undergoing Chemotherapy with or without Radiation After Axillary Surgery [Protocol 10-062]	Heerdt, Alexandra, MD
A Genotype-Phenotype Urothelial Cancer Study [Protocol 09-025]	Bajorin, Dean, MD
A Global Assessment of Medical, Emotional, and Reproductive Concerns in Survivors of Gestational Trophoblastic Disease [Protocol 08-040]	Aghajanian, Carol, MD
A Multicenter Phase II Study of Irinotecan and Alvocidib (Flavopiridol) versus Irinotecan Alone for Patients with p53 Wild-Type Gastric Adenocarcinoma Whose Disease Has Progressed on One Line of Treatment [Protocol 09-074]	Shah, Manish, MD
A Multicenter Phase II Trial of ARQ197 for Patients with Relapsed or Refractory Germ Cell Tumors [Protocol 09-153]	Feldman, Darren, MD
A Multicenter Treatment Protocol for Compassionate Use of Ipilimumab Monotherapy in Patients with Unresectable Stage III or Stage IV Melanoma [Protocol 07-156]	Wolchok, Jedd, MD, PhD
A Multicenter Trial Evaluating Computed Tomography and Serum CA-125 for the Management of Newly Diagnosed Ovarian Cancer [Protocol 01-048]	Chi, Dennis, MD
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma [Protocol 06-150]	Castro-Malaspina, Hugo, MD
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies [Protocol 06-066]	Barker, Juliet, MBBS
A Phase 1 Study of IPI-504 and Docetaxel in Patients with Advanced Solid Tumors [Protocol 07-154]	Riely, Gregory, MD, PhD
A Phase 1B/II Study of GDC-0449 Plus RO4929097 in Advanced/Metastatic Sarcomas [Protocol 10-049]	Schwartz, Gary, MD
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer [Protocol 09-035]	Cox, Brett, MD
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy [Protocol 10-031]	Kollmeier, Marisa, MD
A Phase I Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Patients with Advanced Solid Tumors [Protocol 09-154]	Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of AZD7762 plus Irinotecan in Patients with Advanced Solid Malignancies [Protocol 07-057]	Ho, Alan, MD, PhD
A Phase I Study of CYT 107 in Recipients of HLA-Matched T Cell-Depleted Peripheral Blood Stem Cell or Bone Marrow Transplants [Protocol 07-127]	VanDenBrink, Marcel, MD, PhD
A Phase I Study of Carboplatin/Paclitaxel/Bevacizumab and ABT-888 in Patients with Previously Untreated Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Protocol 09-106]	Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia [Protocol 07-012]	Steinherz, Peter, MD
A Phase I Study of Donor T Cells Sensitized with Pentadecapeptides of the CMV-PP65 Protein for the Treatment of CMV Infections Following Allogeneic Hematopoietic Stem Cell Transplants [Protocol 05-065]	O'Reilly, Richard, MD
A Phase I Study of GC33 plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma [Protocol 10-021]	Abou-Alfa, Ghassan, MD
A Phase I Study of GSK2141795 in Patients with Solid Tumors or Lymphomas [Protocol 09-023]	Aghajanian, Carol, MD
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia [Protocol 06-138]	Brentjens, Renier, MD, PhD
A Phase I Study of HER2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer [Protocol 04-101]	Gilewski, Teresa, MD
A Phase I Study of High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue, Lymph Nodes, or Bone [Protocol 06-101]	Zelefsky, Michael, MD
A Phase I Study of Induction Therapy with Cytarabine, High-Dose Mitoxantrone, and Dasatinib for Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia [Protocol 09-046]	Lamanna, Nicole, MD
A Phase I Study of Intraperitoneal Radioimmunotherapy with ¹³¹I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors [Protocol 09-090]	Modak, Shakeel, MD
A Phase I Study of Intrathecal Radioimmunotherapy Using ¹³¹I-8H9 for Central Nervous System/Leptomeningeal Cancers [Protocol 03-133]	Kramer, Kim, MD
A Phase I Study of KU-0059436 Plus Gemcitabine in Patients with Advanced Pancreatic Cancer [Protocol 09-073]	O'Reilly, Eileen, MD
A Phase I Study of KW-2450 in Patients with Previously Treated Advanced Solid Tumors [Protocol 09-027]	Schwartz, Gary, MD
A Phase I Study of MORAb-004 in Patients with Solid Tumors [Protocol 10-012]	Carvajal, Richard, MD
A Phase I Study of NY-ESO-1 Overlapping Peptides with or without Montanide Vaccination in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Second or Third Remission [Protocol 07-152]	Sabbatini, Paul, MD
A Phase I Study of PF-00477736 with Gemcitabine in Patients with Advanced Solid Malignancies [Protocol 07-017]	Schwartz, Gary, MD
A Phase I Study of PKI-587 in Patients with Solid Tumors [Protocol 09-101]	Bell-McGuinn, Katherine, MD, PhD
A Phase I Study of Panitumumab in Children with Solid Tumors [Protocol 08-020]	Meyers, Paul, MD
A Phase I Study of Perifosine with Temsirolimus for Recurrent Pediatric Solid Tumors [Protocol 09-124]	Becher, Oren, MD
A Phase I Study of Post-Operative Radiation Therapy plus RAD001 (Everolimus) and Cisplatin for Patients with Head and Neck Cancer [Protocol 08-138]	Fury, Matthew, MD, PhD
A Phase I Study of R7112 in Patients with Leukemia or Lymphoma [Protocol 09-075]	Maslak, Peter, MD
A Phase I Study of R7112 in People with Advanced Cancers (Except Leukemia) [Protocol 08-002]	Maki, Robert, MD
A Phase I Study of RAD001 (Everolimus), Docetaxel, and Cisplatin as Induction Chemotherapy for Patients with Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma [Protocol 09-028]	Fury, Matthew, MD, PhD
A Phase I Study of RO4929097 in Combination with Standard Radiotherapy and Temozolomide for Newly Diagnosed Malignant Glioma [Protocol 09-177]	Omuro, Antonio, MD
A Phase I Study of SGN-75 in Patients with CD70-positive Relapsed or Refractory Non-Hodgkin Lymphoma or Metastatic Renal Cell Carcinoma [Protocol 10-044]	Hamlin, Paul, MD
A Phase I Study of STA9090 in Patients with Hematologic Malignancies [Protocol 09-095]	Heaney, Mark, MD, PhD
A Phase I Study of Sunitinib in HIV-Infected Patients with Cancer on HAART Therapy [Protocol 10-026]	Gerecitano, John, MD, PhD
A Phase I Study of U3-1287 (AMG 888), a Human Monoclonal Antibody Targeting HER3, in Patients with Advanced Solid Tumors [Protocol 08-146]	Rizvi, Naiyer, MD
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation [Protocol 07-055]	O'Reilly, Richard, MD
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers [Protocol 06-155]	Aghajanian, Carol, MD
A Phase I Study of XL281 in Patients with Advanced Solid Tumors [Protocol 07-020]	Schwartz, Gary, MD
A Phase I Study of XL765 in Combination with Temozolomide in Patients with Malignant Gliomas [Protocol 08-057]	Omuro, Antonio, MD
A Phase I Study of Yttrium-90 Attached to Chimeric Monoclonal Antibody CG250 in Patients with Advanced Renal Cancer [Protocol 05-031]	Larson, Steven, MD
A Phase I Study of the Combination of MK-2206 and Trastuzumab in HER2-Positive Solid Tumors [Protocol 10-023]	Hudis, Clifford, MD
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19 [Protocol 09-114]	Brentjens, Renier, MD, PhD
A Phase I Trial of Sequential Paclitaxel/Ifosfamide and Dose-Intensive Paclitaxel, Carboplatin, and Dose-Escalated Ifosfamide with Stem Cell Support in Cisplatin- Resistant Germ Cell Tumor Patients [Protocol 06-077]	Feldman, Darren, MD
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma [Protocol 05-075]	Kushner, Brian, MD
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer [Protocol 08-122]	Fornier, Monica, MD
A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients with Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Cancers [Protocol 05-077]	Lamanna, Nicole, MD
A Phase I/IB Study of IMC-20D7S in Patients with Progressive Malignant Melanoma [Protocol 10-069]	Wolchok, Jedd, MD, PhD
A Phase I/II Clinical Trial of Temsirolimus plus Neratinib for Patients with Metastatic HER2-Amplified or Triple-Negative Breast Cancer [Protocol 10-005]	Chandarlapaty, Sarat, MD, PhD
A Phase I/II Study of ARN-509 in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer [Protocol 09-002]	Rathkopf, Dana, MD, PhD
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL) [Protocol 05-103]	Gerecitano, John, MD, PhD
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1 [Protocol 09-165]	Carvajal, Richard, MD
A Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients with Myelodysplastic Syndromes [Protocol 06-054]	Klimek, Virginia, MD
A Phase I/II Study of HE3235 in Patients with Prostate Cancer [Protocol 08-090]	Morris, Michael, MD
A Phase I/II Study of Temsirolimus, Paclitaxel, and Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer [Protocol 09-131]	Fury, Matthew, MD, PhD
A Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer [Protocol 10-039]	Traina, Tiffany, MD
A Phase I/II Study of the Tor Kinase Inhibitor AZD8055 in Patients with Advanced Solid Tumors, Lymphomas, or Endometrial Carcinoma [Protocol 08-093]	Aghajanian, Carol, MD
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders [Protocol 95-024]	O'Reilly, Richard, MD
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies [Protocol 06-125]	Boulad, Farid, MD
A Phase I/II Trial of IMC-A12 plus Temsirolimus in Metastatic Castration-Resistant Prostate Cancer [Protocol 09-117]	Rathkopf, Dana, MD, PhD
A Phase I/II Trial of PTC299 in Patients with HIV-Related Kaposi's Sarcoma [Protocol 08-064]	Krown, Susan, MD
A Phase I/II Trial of Vorinostat in Combination with Cyclophosphamide, Etoposide, Prednisone, and Rituximab for Elderly Patients with Relapsed Diffuse Large B-Cell Lymphoma [Protocol 08-045]	Straus, David, MD
A Phase I/IIA Study of Pralatrexate and Gemcitabine with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Lymphoma [Protocol 07-062]	Horwitz, Steven, MD
A Phase I/IIa Study Evaluating ABT-263 in Patients with Relapsed or Refractory Lymphoid Malignancies [Protocol 07-048]	Gerecitano, John, MD, PhD
A Phase I/IIa Study of Alpharadin^® Plus Docetaxel in Patients with Bone Metastases from Castration-Resistant Prostate Cancer [Protocol 10-086]	Morris, Michael, MD
A Phase IB Study to Assess PTC299 plus Hormonal Therapy in Patients with Metastatic Breast Cancer [Protocol 09-105]	Dickler, Maura, MD
A Phase IB/II study of E7080 plus Everolimus in Patients with Unresectable Advanced/Metastatic Renal Cell Carcinoma [Protocol 10-084]	Motzer, Robert, MD
A Phase II Clinical Trial of ABT-888 Plus Temozolomide versus Pegylated Liposomal Doxorubicin Alone in Patients with Recurrent Ovarian Cancer [Protocol 10-057]	Bell-McGuinn, Katherine, MD, PhD
A Phase II Clinical Trial of Itraconazole in Patients with Metastatic Castration-Resistant Prostate Cancer [Protocol 09-111]	Rathkopf, Dana, MD, PhD
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers [Protocol 07-072]	Barker, Juliet, MBBS
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor [Protocol 01-062]	Boulad, Farid, MD
A Phase II Study Comparing Paclitaxel/Carboplatin/Bevacizumab, Paclitaxel/Carboplatin/Temsirolimus, and Ixabepilone/Carboplatin/Bevacizumab as Initial Therapy for Advanced or Recurrent Endometrial Cancer [Protocol 09-115]	Aghajanian, Carol, MD
A Phase II Study Evaluating IPI-504 Plus Trastuzumab in Patients with Pretreated Locally Advanced or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer [Protocol 09-033]	Modi, Shanu, MD
A Phase II Study Evaluating the Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer [Protocol 09-148]	Sherman, Eric, MD
A Phase II Study of Anti-GD2 Antibody 3F8 and GM-CSF for High-Risk Neuroblastoma [Protocol 03-077]	Kushner, Brian, MD
A Phase II Study of Bendamustine HCl in Relapsed and Primary Refractory Hodgkin's Lymphoma [Protocol 08-041]	Moskowitz, Craig, MD
A Phase II Study of Bevacizumab for Recurrent Malignant Stromal Tumors of the Ovary [Protocol 09-062]	Leitao, Mario, MD
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma [Protocol 10-015]	Modak, Shakeel, MD
A Phase II Study of Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients with Newly Diagnosed Glioblastoma [Protocol 08-126]	Omuro, Antonio, MD
A Phase II Study of Bicalutamide for the Treatment of Androgen-Receptor-Positive, Estrogen- and Progesterone-Receptor-Negative Metastatic Breast Cancer [Protocol 07-022]	Traina, Tiffany, MD
A Phase II Study of CBP501, Pemetrexed, and Cisplatin in Chemotherapy-Naïve Patients with Malignant Pleural Mesothelioma [Protocol 08-082]	Krug, Lee, MD
A Phase II Study of CCI-779 and Bevacizumab in Patients with Endometrial, Ovarian, or Hepatocellular Carcinoma, Carcinoid Tumor, or Islet Cell Cancer [Protocol 09-125]	Reidy-Lagunes, Diane, MD
A Phase II Study of Cisplatin or Carboplatin for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response [Protocol 09-065]	Traina, Tiffany, MD
A Phase II Study of Conformal Radiotherapy in Patients with Low-Grade Gliomas [Protocol 07-049]	Dunkel, Ira, MD
A Phase II Study of Erlotinib and Chemotherapy for Operable Stage IB-IIIA Non-Small Cell Lung Cancer Patients Who Are Nonsmokers or Light Smokers [Protocol 07-103]	Rizvi, Naiyer, MD
A Phase II Study of Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma [Protocol 09-142]	Krug, Lee, MD
A Phase II Study of Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium [Protocol 08-123]	Milowsky, Matthew, MD
A Phase II Study of FOLFOX with and without CT-011 in Patients with Colorectal Cancer Previously Untreated for Metastatic Disease [Protocol 09-022]	Segal, Neil, MD, PhD
A Phase II Study of Five-Year Imatinib (Gleevec^®) in Patients at Significant Risk for Recurrence of Primary Gastrointestinal Stromal Tumor [Protocol 09-061]	DeMatteo, Ronald, MD
A Phase II Study of Flavopiridol Plus Oxaliplatin with or without 5-FU and Leucovorin for Relapsed or Refractory Germ-Cell Tumors [Protocol 09-034]	Feldman, Darren, MD
A Phase II Study of Focal Cryoablation in Low-Risk Prostate Cancer [Protocol 08-118]	Eastham, James, MD
A Phase II Study of GM-CSF (Sargramostim) and Rituximab Following Autologous Transplantation for Relapsed Follicular Lymphoma [Protocol 07-085]	Moskowitz, Craig, MD
A Phase II Study of Gemcitabine and Cisplatin plus Sorafenib in Patients with Advanced Biliary Tract Carcinomas Naïve to Systemic Therapy [Protocol 09-029]	Abou-Alfa, Ghassan, MD
A Phase II Study of Gemcitabine, Cisplatin, and Sunitinib as Chemotherapy Before Surgery in Patients with Muscle-Invasive Bladder Cancer [Protocol 08-159]	Bajorin, Dean, MD
A Phase II Study of IMC-A12 in Children with Relapsed/Refractory Solid Tumors [Protocol 09-172]	Wexler, Leonard, MD
A Phase II Study of Imatinib in Patients with Inoperable Stage III or IV Melanoma with Alterations in the C-KIT Protein [Protocol 07-014]	Carvajal, Richard, MD
A Phase II Study of Imprime PGG^® Injection in Combination with Cetuximab in Patients with Stage IV KRAS-Mutated Colorectal Cancer [Protocol 09-052]	Segal, Neil, MD, PhD
A Phase II Study of Inotuzumab Ozogamicin Plus Rituximab in Patients with Relapsed/Refractory CD22-Positive Diffuse Large B-Cell Lymphoma, Eligible for Autologous Stem Cell Transplantation [Protocol 10-041]	Hamlin, Paul, MD
A Phase II Study of Intrathecal I¹³¹-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms [Protocol 05-122]	Kramer, Kim, MD
A Phase II Study of Lenalidomide in Patients with Chronic Lymphocytic Leukemia Age 65 and Older [Protocol 09-045]	Lamanna, Nicole, MD
A Phase II Study of MK-2206 in Patients with Metastatic Neuroendocrine Tumors [Protocol 10-067]	Reidy-Lagunes, Diane, MD
A Phase II Study of Maitake Mushroom Extract in Patients with Low-Risk, Untreated Myelodysplastic Syndrome [Protocol 09-094]	Wesa, Kathleen, MD
A Phase II Study of Melphalan with Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Systemic Light-Chain Amyloidosis [Protocol 07-006]	Landau, Heather, MD
A Phase II Study of Midostaurin in Patients with Aggressive Systemic Mastocytosis or Mast Cell Leukemia [Protocol 10-006]	Heaney, Mark, MD, PhD
A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients with Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma [Protocol 07-113]	O'Reilly, Eileen, MD
A Phase II Study of Nilotinib (AMN107) in Patients with Metastatic Mucosal, Acral, or Chronically Sun-Damaged Melanoma [Protocol 09-055]	Carvajal, Richard, MD
A Phase II Study of Oral ENMD-2076 in Patients with Platinum-Resistant Ovarian Cancer [Protocol 10-064]	Tew, William, MD
A Phase II Study of PF-00299804 in Patients with Untreated Advanced Lung Adenocarcinoma [Protocol 10-080]	Miller, Vincent, MD
A Phase II Study of PF-02341066 in Patients with Advanced Non-Small Cell Lung Cancer and the ALK Gene Fusion [Protocol 10-009]	Riely, Gregory, MD, PhD
A Phase II Study of Panobinostat in Patients with Refractory Acute Myelogenous Leukemia [Protocol 10-001]	Klimek, Virginia, MD
A Phase II Study of Pentostatin with Cyclophosphamide and Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia [Protocol 05-051]	Lamanna, Nicole, MD
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS [Protocol 08-008]	Castro-Malaspina, Hugo, MD
A Phase II Study of Pre-Operative Chemotherapy Plus Bevacizumab with Early Salvage Therapy in Patients with Locally Advanced Resectable Gastric and Gastroesophageal Junction Adenocarcinoma [Protocol 08-081]	Shah, Manish, MD
A Phase II Study of RAD001 (Everolimus) for Children with Chemotherapy and/or Refractory Progressive or Recurrent Low-Grade Gliomas [Protocol 10-047]	Gilheeney, Stephen, MD
A Phase II Study of RAD001 and Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma [Protocol 09-113]	Motzer, Robert, MD
A Phase II Study of RO5072759 versus Rituximab in Patients with Relapsed Indolent B-Cell Non-Hodgkin's Lymphoma [Protocol 09-162]	Zelenetz, Andrew, MD
A Phase II Study of Radiation Therapy, Cetuximab, and Irinotecan in Children and Young Adults with Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas [Protocol 09-014]	Dunkel, Ira, MD
A Phase II Study of Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue in Newly Diagnosed Primary CNS Lymphoma [Protocol 04-129]	Omuro, Antonio, MD
A Phase II Study of Romidepsin in Progressive or Relapsed Peripheral T-Cell Lymphoma Following Prior Systemic Therapy [Protocol 07-095]	Horwitz, Steven, MD
A Phase II Study of STA-9090 in Patients with Refractory Metastatic Colorectal Cancer [Protocol 10-029]	Saltz, Leonard, MD
A Phase II Study of Short-Course Androgen Deprivation (Hormonal) Therapy with or without Bevacizumab for PSA Recurrence of Prostate Cancer after Definitive Local Therapy [Protocol 09-123]	Slovin, Susan, MD, PhD
A Phase II Study of TKI258 in Patients with Advanced Urothelial Carcinoma [Protocol 10-058]	Milowsky, Matthew, MD
A Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer [Protocol 08-065]	Pietanza, M. Catherine, MD
A Phase II Study of Temsirolimus and IGF-1 receptor antibody IMC-A12 in Patients with Metastatic Sarcomas [Protocol 09-097]	Maki, Robert, MD
A Phase II Study of the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer [Protocol 08-150]	Kauff, Noah, MD
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma [Protocol 08-053]	Krug, Lee, MD
A Phase II Trial of AZD6244 in Patients with V600E BRAF-Mutated Melanomas [Protocol 09-003]	Chapman, Paul, MD
A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma [Protocol 10-014]	Goodman, Karyn, MD
A Phase II Trial of Bevacizumab, Cetuximab, Cisplatin, and Intensity-Modulated Radiation Therapy for Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma [Protocol 09-083]	Fury, Matthew, MD, PhD
A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgery in Patients with Locally Advanced Thymoma [Protocol 09-038]	Huang, James, MD
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients with Recurrent Malignant Glioma [Protocol 07-064]	Omuro, Antonio, MD
A Phase II Trial of Dasatinib in Patients with Recurrent Glioblastoma Multiforme [Protocol 07-042]	Lassman, Andrew, MD
A Phase II Trial of Erlotinib in Patients with Resected, Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor Mutations [Protocol 08-152]	Azzoli, Christopher, MD
A Phase II Trial of Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer [Protocol 09-008]	Morris, Michael, MD
A Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy-naïve Patients with Advanced/Metastatic Urothelial Carcinoma [Protocol 06-006]	Bajorin, Dean, MD
A Phase II Trial of Gemcitabine, Carboplatin, and Cetuximab with or without IMC-A12 In Chemotherapy-Naïve Patients with Advanced Non- Small Cell Lung Cancer [Protocol 08-154]	Rizvi, Naiyer, MD
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant [Protocol 07-035]	Hsu, Katharine, MD, PhD
A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia [Protocol 08-031]	Boulad, Farid, MD
A Phase II Trial of Intensive Chemotherapy & Autotransplantation in Patients with Newly Diagnosed Anaplastic Oligodendroglioma [Protocol 02-089]	Omuro, Antonio, MD
A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma [Protocol 03-099]	Wexler, Leonard, MD
A Phase II Trial of Irinotecan, Cisplatin, Bevacizumab, and Concurrent Radiotherapy in Locally Advanced Esophageal Adenocarcinoma [Protocol 06-013]	Ilson, David, MD
A Phase II Trial of Liposomal Doxorubicin (Doxil^®) Followed by Bexarotene (Targretin^®) in Advanced Cutaneous T-Cell Lymphoma [Protocol 05-098]	Straus, David, MD
A Phase II Trial of Paclitaxel, Pemetrexed, and Bevacizumab in Patients with Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects, and Automated Response Assessment [Protocol 08-109]	Pietanza, M. Catherine, MD
A Phase II Trial of Sorafenib and Dacarbazine in Soft-Tissue Sarcoma [Protocol 08-068]	D'Adamo, David, MD
A Phase II Trial of Sunitinib (Sutent^®) in Patients with Recurrent or Inoperable Meningioma [Protocol 07-135]	Kaley, Thomas, MD
A Phase II Trial of Temozolomide and Radiotherapy Followed by Temozolomide and Maintenance Cis-retinoic Acid for Patients with Newly Diagnosed Gliomas [Protocol 05-079]	Lassman, Andrew, MD
A Phase II Trial of Temsirolimus or the Combination of Hormonal Therapy Plus Temsirolimus in Women with Advanced, Persistent, or Recurrent Endometrial Carcinoma [Protocol 09-019]	Makker, Vicky, MD
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders [Protocol 10-050]	O'Reilly, Richard, MD
A Phase II Trial of a KLH-Conjugated Trivalent Ganglioside Vaccine with OPT-821 versus OPT-821 Alone in Metastatic Sarcoma Patients with No Evidence of Disease [Protocol 08-153]	Carvajal, Richard, MD
A Phase IIB Study of Pioglitazone for Oral Precancers [Protocol 09-163]	Boyle, Jay, MD
A Phase III Clinical Trial of Bevacizumab with Intravenous versus Intraperitoneal Chemotherapy for Treating Stage II-IV Ovarian, Fallopian Tube, and Primary Peritoneal Cancers [Protocol 09-167]	Leitao, Mario, MD
A Phase III Comparison of Standard-Dose Versus High-Dose Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel with or without Cetuximab in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer [Protocol 09-135]	Gelblum, Daphna, MD
A Phase III Study Assessing Carboplatin and/or Isotretinoin plus Radiation in Patients with Supratentorial Primitive Neuroectodermal Tumor or High-Risk Medulloblastoma [Protocol 07-174]	Gilheeney, Stephen, MD
A Phase III Study Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Treated without Surgery [Protocol 09-066]	Goodman, Karyn, MD
A Phase III Study of ABVD with or without Rituximab for Patients with Advanced-Stage Classical Hodgkin Lymphoma with Poor-Risk Features [Protocol 08-063]	Portlock, Carol, MD
A Phase III Study of Adjuvant Sunitinib versus Placebo in Patients with High-Risk Renal Cell Carcinoma [Protocol 07-086]	Motzer, Robert, MD
A Phase III Study of Androgen Deprivation with Leuprolide with or without Docetaxel for Clinically Asymptomatic Prostate Cancer Patients with a Rising PSA Following Surgery [Protocol 07-101]	Morris, Michael, MD
A Phase III Study of Beclomethasone plus High-Dose Prednisone for the Treatment of Patients with Gastrointestinal Graft vs. Host Disease [Protocol 09-152]	Perales, Miguel-Angel, MD
A Phase III Study of Carboplatin and Paclitaxel Alone or with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Protocol 08-074]	Leitao, Mario, MD
A Phase III Study of Cisplatin and Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel Alone for Advanced Endometrial Carcinoma [Protocol 09-145]	Leitao, Mario, MD
A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer [Protocol 05-068]	McCormick, Beryl, MD
A Phase III Study of Docetaxel and Gemcitabine With or Without Bevacizumab in Women with Recurrent or Advanced Leiomyosarcoma of the Uterus [Protocol 10-048]	Hensley, Martee, MD
A Phase III Study of Docetaxel with and without Dasatinib in Castration-Resistant Prostate Cancer [Protocol 09-050]	Morris, Michael, MD
A Phase III Study of Fulvestrant with or without Lapatinib (Tykerb^®) for Postmenopausal Women with Hormone-Receptor-Positive Advanced Breast Cancer [Protocol 07-122]	Lake, Diana, MD
A Phase III Study of Intensive Induction Chemotherapy with or without Methotrexate Followed by Consolidation Therapy with Stem Cell Rescue in Young Children Newly Diagnosed with Supratentorial PNET or High-Risk Medulloblastoma [Protocol 07-170]	Gilheeney, Stephen, MD
A Phase III Study of Ipilimumab versus Placebo after Complete Resection of High-Risk Stage III Melanoma [Protocol 08-085]	Wolchok, Jedd, MD, PhD
A Phase III Study of MDV3100 in Patients with Progressive Castration-Resistant Prostate Cancer Previously Treated with Docetaxel-Based Chemotherapy [Protocol 09-085]	Scher, Howard, MD
A Phase III Study of Mitomycin C versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer [Protocol 09-118]	Dalbagni, Guido, MD
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma [Protocol 08-072]	Dunkel, Ira, MD
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer [Protocol 07-041]	Eastham, James, MD
A Phase III Study of PF-02341066 versus Standard Chemotherapy (Pemetrexed or Docetaxel) in Patients with Advanced Non-Small Cell Lung Cancer and the ALK Gene Fusion [Protocol 10-008]	Riely, Gregory, MD, PhD
A Phase III Study of PLX4032 (RO5185426) versus Dacarbazine in Previously Untreated Patients with Unresectable Stage IIIC or Stage IV Melanoma [Protocol 09-175]	Chapman, Paul, MD
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus [Protocol 10-007]	Hensley, Martee, MD
A Phase III Study of SGN-35 versus Placebo in Patients at High Risk of Residual Hodgkin Lymphoma After Autologous Stem Cell Transplant [Protocol 10-027]	Moskowitz, Craig, MD
A Phase III Study of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy in Patients with Cutaneous Melanomas that Have Metastasized to the Sentinel Node [Protocol 09-112]	Ariyan, Charlotte, MD
A Phase III Study of a Pneumococcal Conjugate Vaccine Followed by a Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplants [Protocol 09-180]	Small, Trudy, MD
A Phase III Study to Compare Tivozanib (AV-951) with Sorafenib in Patients with Advanced Renal Cell Carcinoma [Protocol 09-181]	Motzer, Robert, MD
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer [Protocol 10-083]	Goodman, Karyn, MD
A Phase III Trial Evaluating Corticosteroids with and without Mycophenolate Mofetil as Initial Treatment of Acute GVHD [Protocol 10-063]	Perales, Miguel-Angel, MD
A Phase III Trial of Cisplatin plus Paclitaxel with and without Bevacizumab versus Topotecan plus Paclitaxel, with and without Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix [Protocol 09-098]	Leitao, Mario, MD
A Phase III Trial of Cyclophosphamide and Doxorubicin Versus Paclitaxel as Adjuvant Therapy for Women with Node-Negative Breast Cancer [Protocol 04-042]	Lake, Diana, MD
A Phase III Trial of Hormonal Therapy Alone or with Bevacizumab in Women with Locally Advanced or Metastatic Hormone-Receptor-Positive Breast Cancer [Protocol 08-094]	Dickler, Maura, MD
A Phase III Trial of Ipilimumab or Placebo Following Radiotherapy in Patients with Castration-Resistant Prostate Cancer Who Had Prior Treatment with Docetaxel [Protocol 09-126]	Slovin, Susan, MD, PhD
A Phase III Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy [Protocol 05-095]	Krug, Lee, MD
A Phase III Trial of Paclitaxel versus Nanoparticle Albumin-Bound Paclitaxel or Ixabepilone plus Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer [Protocol 09-100]	Lake, Diana, MD
A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Carcinoma [Protocol 09-174]	Aghajanian, Carol, MD
A Phase III Trial of Short-Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed-Only Radiotherapy in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy [Protocol 09-102]	Zelefsky, Michael, MD
A Phase IIb Study of Gemcitabine with or without Sorafenib in Women with Locally Advanced or Metastatic Breast Cancer That Has Progressed During or After Bevacizumab Therapy [Protocol 07-131]	Hudis, Clifford, MD
A Phase Ib Study of MDX-1106 (BMS-936558) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma [Protocol 09-155]	Wolchok, Jedd, MD, PhD
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies [Protocol 09-012]	Carvajal, Richard, MD
A Phase Ib Study of Trastuzumab-MCC-DM1, Paclitaxel, and Pertuzumab in Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer Who Previously Received Trastuzumab [Protocol 09-093]	Modi, Shanu, MD
A Phase Ib Study of the Anti-VEGF Agent PTC299 in Patients with Advanced Cancer [Protocol 08-043]	Schwartz, Gary, MD
A Phase Ib/IIa Study of AV-951 in Combination with Paclitaxel in Patients with Advanced or Metastatic Breast Cancer [Protocol 08-136]	Dickler, Maura, MD
A Phase Ib/IIa Study of AV-951 in Patients with Advanced Non-Small Cell Lung Cancer [Protocol 08-144]	Rizvi, Naiyer, MD
A Pilot Phase II Study of Targeted Radiotherapy with ¹³¹I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors [Protocol 04-148]	Modak, Shakeel, MD
A Pilot Study Surveying Female Cancer Patients' Preference for Sexual Health Interventions [Protocol 10-034]	Carter, Jeanne, PhD
A Pilot Study of Docetaxel plus Vinorelbine as Adjuvant Chemotherapy for Patients with Resected Non-Small Cell Lung Cancer [Protocol 07-178]	Azzoli, Christopher, MD
A Pilot Study of High Dose-Rate Prostate Brachytherapy as Salvage Therapy for Locally Recurrent Prostate Cancer Previously Treated with External Beam Radiotherapy [Protocol 06-122]	Yamada, Yoshiya, MD
A Pilot Study of High-Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer [Protocol 07-120]	Yamada, Yoshiya, MD
A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease [Protocol 07-029]	Chi, Dennis, MD
A Pilot Trial Assessing the Safety and Immunogenicity of the GI-4000 Vaccine as Consolidation Therapy after Curative Treatment for Stage I-III Non-Small Cell Lung Cancers with K-ras Mutations [Protocol 07-149]	Azzoli, Christopher, MD
A Pilot Trial to Assess the Feasibility and Safety of G-CSF Mobilization of Hematopoietic Stem Cells in Patients with Beta-thalassemia Major [Protocol 08-030]	Boulad, Farid, MD
A Pivotal Study of ExAblate Treatment for the Relief of Pain in Patients with Metastatic Bone Tumors Who Are Not Candidates for Radiation Therapy [Protocol 08-131]	Maybody, Majid, MD
A Prospective Analysis of Surgery in Patients Presenting with Stage IV Breast Cancer [Protocol 09-056]	King, Tari, MD
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration [Protocol 05-001]	Chi, Dennis, MD
A Prospective Study of Quality of Life in Patients with Invasive Bladder Cancer [Protocol 08-076]	Bochner, Bernard, MD
A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy [Protocol 07-130]	Ahles, Tim, PhD
A Prospective, Randomized Trial Comparing Robotic and Open Radical Cystectomy [Protocol 10-016]	Laudone, Vincent, MD
A Randomized Controlled Trial of Family-Focused Grief Therapy in Palliative Care and Bereavement [Protocol 05-120]	Kissane, David, MD
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer [Protocol 06-103]	Shah, Manish, MD
A Randomized Study of MORAb-003 (Farletuzumab) Plus Paclitaxel in Patients with Platinum-Resistant or Refractory Relapsed Ovarian Cancer [Protocol 08-149]	Konner, Jason, MD
A Randomized Trial of Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy [Protocol 09-005]	Mulhall, John, MD
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia [Protocol 08-087]	Barker, Juliet, MBBS
A Study Assessing the Use of AlloDerm in Two-Stage, Tissue Expander/Implant Breast Reconstruction [Protocol 08-024]	Disa, Joseph, MD
A Study Comparing Beads with Doxorubicin-Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma [Protocol 07-099]	Brown, Karen, MD
A Study of Avanafil for the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy [Protocol 09-064]	Mulhall, John, MD
A Study of Brivanib in Patients with Advanced Tumors [Protocol 08-061]	Schwartz, Gary, MD
A Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma [Protocol 10-051]	Koehne, Guenther, MD, PhD
A Study of Cilengitide (EMD 121974) in Recurrent or Progressive and Refractory Childhood High-Grade Glioma [Protocol 08-143]	Gilheeney, Stephen, MD
A Study of Deforolimus (MK-8669) in Non-Small Cell Lung Cancer Patients with KRAS Mutations [Protocol 09-047]	Riely, Gregory, MD, PhD
A Study of Group Psychotherapy Interventions for People with Cancer [Protocol 07-094]	Breitbart, William, MD
A Study of Intravenous Oseltamivir for the Treatment of Influenza in Patients Age 13 and Older [Protocol 10-004]	Papanicolaou, Genovefa, MD
A Study of Ofatumumab plus DHAP Chemotherapy in Relapsed or Refractory Aggressive Lymphoma [Protocol 09-082]	Matasar, Matthew, MD
A Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin's Lymphoma [Protocol 07-147]	Perales, Miguel-Angel, MD
A Study of Temsirolimus and Sorafenib as Second-Line Therapy in Patients with Advanced Renal Cell Carcinoma that Has Grown Despite First-Line Sunitinib Therapy [Protocol 07-124]	Motzer, Robert, MD
A Study of [¹⁸F]-ML-10 as a PET Imaging Radiotracer for the Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy [Protocol 08-116]	Beal, Kathryn, MD
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma [Protocol 09-171]	Landau, Heather, MD
AAML0431 for the Treatment of Young Down Syndrome Children with Acute Myeloid Leukemia and Myelodysplastic Syndrome [Protocol 09-080]	Shukla, Neerav, MD
ALTE03N1: Key Adverse Events Following Childhood Cancer [Protocol 05-070]	Sklar, Charles, MD
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant [Protocol 07-092]	Oeffinger, Kevin, MD
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients [Protocol 04-144]	Hurley, Karen, PhD
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer [Protocol 08-017]	Dang, Chau, MD
Adolescent and Young Adult Cancer Survivors: Identity Development [Protocol 09-001]	Ford, Jennifer, PhD
Adoptive Transfer of Autologous T Cells Targeted to Prostate-Specific Membrane Antigen for the Treatment Of Castrate Metastatic Prostate Cancer [Protocol 09-036]	Slovin, Susan, MD, PhD
Adult Long-Term Follow-Up Quality Improvement Project [Protocol 10-066]	Tonorezos, Emily, MD, MPH
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders [Protocol 00-069]	Offit, Kenneth, MD
Assessing the Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy [Protocol 08-135]	Mulhall, John, MD
Assessing the Interplay Among BRCA1, SIRT1, and Aromatase in Breast Cancer [Protocol 10-017]	Hudis, Clifford, MD
BRCA1 Haploinsufficiency and Gene Expression [Protocol 04-045]	King, Tari, MD
Biaxin (Clarithromycin)-Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma [Protocol 07-038]	Portlock, Carol, MD
Biomarkers of Molecular Risk in Smokers [Protocol 04-141]	Boyle, Jay, MD
Carcinogen Metabolism, DNA Repair, Parental Exposures, and Retinoblastoma [Protocol 08-129]	Dunkel, Ira, MD
Chemotherapy Decisions and Outcomes in Women Age 65 or Older with Operable, Newly Diagnosed Breast Cancer [Protocol 04-030]	Lake, Diana, MD
Classification of Acute Lymphoblastic Leukemia [Protocol 06-023]	Shukla, Neerav, MD
Clinical Outcomes in Hereditary Cancer [Protocol 06-004]	Robson, Mark, MD
Clinical Significance of Germline BRCA Mutations [Protocol 96-051]	Offit, Kenneth, MD
Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants [Protocol 06-024]	Disa, Joseph, MD
Collection of Saliva Samples for Genetic Epidemiology Studies of Cancer and Aging [Protocol 06-102]	Offit, Kenneth, MD
Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information [Protocol 09-133]	Salz, Talya, PhD
Combination of Targeted I¹³¹-3F8-Mediated Radioimmunotherapy and Bevacizumab in Patients with Relapsed or Refractory Neuroblastoma: A Phase I Study [Protocol 06-072]	Modak, Shakeel, MD
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy [Protocol 06-014]	Barker, Juliet, MBBS
Defibrotide for Patients with Hepatic Veno-Occlusive Disease [Protocol 08-060]	Kernan, Nancy, MD
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction [Protocol 07-098]	Pusic, Andrea, MD, MHS
Dual-Energy Contrast-Enhanced Digital Mammography for the Detection and Preoperative Staging of Breast Cancer [Protocol 10-024]	Jochelson, Maxine, MD
EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer [Protocol 10-104]	Oeffinger, Kevin, MD
Early Onset and Familial Gastric Cancer Registry [Protocol 05-118]	Shah, Manish, MD
Electronic Patient-Reported Outcomes from Home in Patients Recovering from Major Gynecologic Cancer Surgery: Measuring Symptoms and Quality of Life [Protocol 08-155]	Chi, Dennis, MD
Erlotinib for the Prevention of Oral Cancer [Protocol 08-023]	Boyle, Jay, MD
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life [Protocol 10-071]	Blinder, Victoria, MD
Evaluating Treatment Summaries and Survivorship Care Plans within the Lance Armstrong Foundation Centers of Excellence Network [Protocol 10-077]	McCabe, Mary, RN, MA
Evaluating the Causes of Cancer in Young Patients [Protocol 09-068]	Stadler, Zsofia, MD
Evaluation of Freezing Kidney Cancer Followed by Confirmation with Biopsy or Resection [Protocol 09-108]	Solomon, Stephen, MD
Expanded Access of Prochymal^¿ Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD [Protocol 09-072]	Prockop, Susan, MD
Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial [Protocol 08-062]	Bartell, Abraham, MD
Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients [Protocol 04-070]	Lee, Nancy, MD
Feasibility Study of STAR, an Internet-based System for Cancer Patients, to Self-report Toxicity Symptoms, Performance Status, and Quality of Life [Protocol 04-020]	Basch, Ethan, MD
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia [Protocol 06-056]	Castro-Malaspina, Hugo, MD
Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging to Assess Tongue Function after Treatment for Tongue Cancer [Protocol 02-093]	Kraus, Dennis, MD
GLIOGENE: Genetic Epidemiology of Glioma International Consortium [Protocol 07-137]	Bernstein, Jonine, PhD
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients [Protocol 03-123]	Meyers, Paul, MD
Genetics of Treatment-Related Cognitive and Brain Structural Changes in Brain Tumor Survivors [Protocol 09-151]	Correa, Denise, PhD
Health Communication in Families [Protocol 03-088]	Ostroff, Jamie, PhD
Health-Related Outcomes for Hodgkin's Disease Survivors [Protocol 06-140]	Trippett, Tanya, MD
Hereditary Colorectal Cancer Family Registry [Protocol 01-110]	Guillem, Jose, MD
Illness Related Distress in Women with Clinically Localized Cutaneous Melanoma [Protocol 08-096]	Brady, Mary, MD
Image-Guided Stereotactic Biopsy of High Grade Gliomas [Protocol 09-060]	Bradbury, Michelle, MD
Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging [Protocol 05-036]	Kraus, Dennis, MD
Inamed Corporation-Style 410 Silicone-Filled Breast Implant Continued Assess Reconstruction/Revision Expansion (CARE) Clinical Study [Protocol 06-076]	Cordeiro, Peter, MD
Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine (L-MTP-PE): Compassionate Access for High-Risk Osteosarcoma [Protocol 08-021]	Meyers, Paul, MD
Longitudinal Assessment of Health-Related Quality of Life in Men with Localized Prostate Cancer [Protocol 02-042]	Scardino, Peter, MD
Measuring Patient Expectations for Breast Reconstruction [Protocol 07-024]	Pusic, Andrea, MD, MHS
Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument [Protocol 05-058]	Pusic, Andrea, MD, MHS
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns [Protocol 06-128]	Oliveria, Susan, ScD, MPH
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry [Protocol 02-102]	Kurtz, Robert, MD
Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief [Protocol 07-150]	Pusic, Andrea, MD, MHS
Molecular Characterization of Neuroblastic Tumors and Clinical Outcome [Protocol 00-109]	Cheung, Nai-Kong, MD, PhD
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer [Protocol 06-163]	Chandarlapaty, Sarat, MD, PhD
Multimodality Treatment for Patients with Resectable Non-Small Cell Lung Cancer (BEACON Study: BEvacizumab And Chemotherapy for Operable NSCLC) [Protocol 05-052]	Rizvi, Naiyer, MD
Pain and Quality of Life in Cancer Survivors [Protocol 07-068]	Passik, Steven, PhD
Participation in the National Marrow Donor Program Registry [Protocol 90-091]	Kernan, Nancy, MD
Phase I Feasibility and Safety Study Using Preoperative High-Dose Single Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High Risk for Extraprostatic Cancer [Protocol 09-013]	Eastham, James, MD
Phase I Study of Aflibercept With or After Radiation Therapy and Temozolomide in Patients with Malignant Glioma [Protocol 08-106]	Omuro, Antonio, MD
Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma [Protocol 09-011]	Modak, Shakeel, MD
Phase I Study of PF-02341066 in People with Advanced Cancer [Protocol 07-157]	Maki, Robert, MD
Phase I Study of Selective Internal Radiation Therapy in Patients with Unresectable Colorectal Cancer Liver Metastases Persisting Despite Hepatic Arterial Chemotherapy [Protocol 09-030]	Sofocleous, Constantinos, MD, PhD
Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors [Protocol 08-091]	Becher, Oren, MD
Phase I Study of Weekly Nanoparticle Albumin-Bound Paclitaxel with Cetuximab and Intensity-Modulated Radiation Therapy in Patients with Locally Advanced Head and Neck Cancer [Protocol 08-084]	Fury, Matthew, MD, PhD
Phase I Study of Xenogeneic CD20 DNA Vaccination in Patients with B-cell Lymphoma [Protocol 07-100]	Palomba, M. Lia, MD
Phase I/II Study of Vandetanib with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma [Protocol 08-137]	Kaley, Thomas, MD
Phase I/II Trial of Temsirolimus and Perifosine for Recurrent or Progressive Malignant Gliomas [Protocol 09-058]	Lassman, Andrew, MD
Phase II Clinical Trial of AZD6244 in Cancers with BRAF Mutations [Protocol 10-010]	Riely, Gregory, MD, PhD
Phase II Prospective Clinical Trial of Vaccine Responses in Childhood Survivors of Cancer Who Had Chemotherapy [Protocol 07-088]	Small, Trudy, MD
Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients Age 65 and Older [Protocol 08-005]	Small, Trudy, MD
Phase II Study of AMG 386 and Sorafenib as First-Line Therapy for Patients with Advanced or Inoperable Hepatocellular Carcinoma [Protocol 09-076]	Abou-Alfa, Ghassan, MD
Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low- Grade and Anaplastic Ependymoma [Protocol 09-031]	Omuro, Antonio, MD
Phase II Study of Monthly SOM230C for Recurrent/Progressive Meningioma [Protocol 10-061]	Kaley, Thomas, MD
Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Patients with Previously Untreated Advanced Germ Cell Tumors [Protocol 07-044]	Feldman, Darren, MD
Phase II Trial of Sorafenib for Patients with Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer [Protocol 09-016]	Ilson, David, MD
Phase II Trial of Temozolomide versus AZD6244 in Patients with Metastatic Uveal Melanoma [Protocol 10-053]	Carvajal, Richard, MD
Physical Activity Intervention for Lung Cancer Survivors [Protocol 08-067]	Ostroff, Jamie, PhD
Pilot Evaluation of Radioimmunodetection of ¹²⁴Iodine-labeled Humanized A33 Antibody (¹²⁴I-huA33) in Patients with Colorectal Cancer [Protocol 03-124]	Larson, Steven, MD
Pilot Study of Molecular Imaging Using Positron Emission Tomography (PET) to Determine Protein and Gene Expression Signatures of Colonic Polyps [Protocol 07-114]	Gollub, Marc, MD
Pilot Study of Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer Requiring Treatment of the Internal Mammary Lymph Nodes [Protocol 10-025]	Ho, Alice, MD
Pilot Study of Sulindac, a Pan-COX Inhibitor, in Oral Premalignant Lesions [Protocol 04-099]	Boyle, Jay, MD
Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients [Protocol 09-116]	Roth, Andrew, MD
Pilot Trial to Determine Toxicity and Antibody Responses with a Vaccine Containing GD2 Lactone and GD3 Lactone in Patients with Disease-Free Stage III or IV Melanoma [Protocol 06-086]	Chapman, Paul, MD
Prospective Assessment of Clinical and Quality of Life Outcomes After Open or Laparoscopic Radical Prostatectomy [Protocol 04-094]	Eastham, James, MD
Quality of Life and Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) Lobectomy versus Thoracotomy and Lobectomy [Protocol 05-006]	Rizk, Nabil, MD
Reacquisition of RAI Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment with AZD6244: A Pilot Study [Protocol 09-048]	Leboeuf, Rebecca, MD
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life [Protocol 08-019]	Dunkel, Ira, MD
Risk for Cognitive Decline in Older Women with Breast Cancer [Protocol 10-079]	Ahles, Tim, PhD
Risk-Adapted Therapy for Patients With Untreated Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B-Cell Lymphoma [Protocol 08-026]	Moskowitz, Craig, MD
Screening for Depression in Lung Cancer Patients [Protocol 06-038]	Passik, Steven, PhD
Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen [Protocol 09-110]	Castiel, Mercedes, MD
Serum Protein Profiling to Characterize Patient Risk in Men Undergoing Radical Prostatectomy [Protocol 04-132]	Eastham, James, MD
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated with Radiation Therapy and Chemotherapy [Protocol 06-162]	Correa, Denise, PhD
Study of Bortezomib plus (R)ICE in Subjects with Relapsed/Refractory AIDS-Associated Non-Hodgkin's Lymphoma [Protocol 09-063]	Noy, Ariela, MD
Support Needs and Preferences of Family Caregivers of Lung Cancer Patients [Protocol 09-104]	Ostroff, Jamie, PhD
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men with Prostate Cancer Age 65 and Older [Protocol 06-084]	Nelson, Christian, PhD
The OPAL Study: A Phase II Study of Tosedostat (CHR-2797) in Elderly Subjects with Refractory or Relapsed Acute Myeloid Leukemia [Protocol 10-002]	Jurcic, Joseph, MD
The Sexual Health of Rectal Cancer Patients: A Pilot Study [Protocol 08-073]	DuHamel, Katherine, PhD
Treatment of Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation [Protocol 09-070]	Dunkel, Ira, MD
Treatment of Children with All Stages of Hepatoblastoma [Protocol 10-046]	Kobos, Rachel, MD
Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer [Protocol 09-107]	Lichtenthal, Wendy, PhD
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide in Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma [Protocol 05-032]	Wexler, Leonard, MD
Vitamin D Levels in Stage IV Colorectal Cancer Patients: A Phase II Study [Protocol 09-143]	Wesa, Kathleen, MD
[¹⁸F]FACBC PET imaging for gliomas [Protocol 08-142]	Lassman, Andrew, MD